Alejandro L Escalaya1, Jose F Tellez-Zenteno2, David A Steven3, Jorge G Burneo4. 1. Epilepsy Program, Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. 2. Division of Neurology, Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. 3. Epilepsy Program, Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. 4. Epilepsy Program, Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: jburneo2@uwo.ca.
Abstract
PURPOSE: To assess the mortality related to epilepsy in Latin America. METHODS: We searched MEDLINE, EMBASE, and LILACS from inception to December 2013 for articles evaluating mortality in patients with epilepsy in Latin America. Studies were included if they evaluated any mortality outcome, included a population of subjects with recurrent seizures or epilepsy, and contained original data analysis. RESULTS: The search strategy yielded 177 publications in MEDLINE and EMBASE, and 59 publications in LILACS; of which 18 met inclusion criteria for our overall review of epilepsy and mortality in Latin America. Most excluded studies did not report the mortality or lacked original data. We also included two references obtained from 2 non-systematic reviews fulfilling our inclusion criteria, and able to provide data for our analyses. Five studies reported Standardized Mortality Ratio (SMR), and demonstrated that people with epilepsy had a higher risk of death than the general population. The SMRs reported in two community-based studies were 1.34 and 2.45. CONCLUSION: The information about mortality in epilepsy in Latin America is very scarce. Comparisons cannot be made among studies due to methodological differences. More studies are needed.
PURPOSE: To assess the mortality related to epilepsy in Latin America. METHODS: We searched MEDLINE, EMBASE, and LILACS from inception to December 2013 for articles evaluating mortality in patients with epilepsy in Latin America. Studies were included if they evaluated any mortality outcome, included a population of subjects with recurrent seizures or epilepsy, and contained original data analysis. RESULTS: The search strategy yielded 177 publications in MEDLINE and EMBASE, and 59 publications in LILACS; of which 18 met inclusion criteria for our overall review of epilepsy and mortality in Latin America. Most excluded studies did not report the mortality or lacked original data. We also included two references obtained from 2 non-systematic reviews fulfilling our inclusion criteria, and able to provide data for our analyses. Five studies reported Standardized Mortality Ratio (SMR), and demonstrated that people with epilepsy had a higher risk of death than the general population. The SMRs reported in two community-based studies were 1.34 and 2.45. CONCLUSION: The information about mortality in epilepsy in Latin America is very scarce. Comparisons cannot be made among studies due to methodological differences. More studies are needed.
Authors: Gisele Sampaio Silva; Nelson J Maldonado; Jorge H Mejia-Mantilla; Santiago Ortega-Gutierrez; Jan Claassen; Panayiotis Varelas; Jose I Suarez Journal: Neurocrit Care Date: 2019-12 Impact factor: 3.210
Authors: Gabriel Crevier-Sorbo; Tristan Brunette-Clément; Edgar Medawar; Francois Mathieu; Benjamin R Morgan; Laureen Hachem; Aria Fallah; Alexander G Weil; George M Ibrahim Journal: Epilepsia Open Date: 2020-03-02
Authors: Francis Levira; David J Thurman; Josemir W Sander; W Allen Hauser; Dale C Hesdorffer; Honorati Masanja; Peter Odermatt; Giancarlo Logroscino; Charles R Newton Journal: Epilepsia Date: 2016-12-18 Impact factor: 5.864